These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15663763

  • 21. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males.
    Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S, Tokunaga K.
    J Am Soc Nephrol; 2006 Mar; 17(3):823-30. PubMed ID: 16421229
    [Abstract] [Full Text] [Related]

  • 22. Gene polymorphism association studies in dialysis: bone and mineral metabolism.
    Erturk S, DialGene Consortium.
    Semin Dial; 2006 Mar; 19(3):232-7. PubMed ID: 16689975
    [Abstract] [Full Text] [Related]

  • 23. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J, Obeidová H, Lenícek M, Stekrová J, Merta M, Maixnerová D, Vítek L, Viklický O, Tesar V.
    Kidney Blood Press Res; 2008 Mar; 31(6):398-403. PubMed ID: 19060482
    [Abstract] [Full Text] [Related]

  • 24. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
    Zhang WX, Chen B, Zhang W, Chen N, Yu ZC, Cai WM.
    Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
    [Abstract] [Full Text] [Related]

  • 25. Pharmacogenomics and nutrigenomics: synergies and differences.
    Ghosh D, Skinner MA, Laing WA.
    Eur J Clin Nutr; 2007 May; 61(5):567-74. PubMed ID: 17213870
    [Abstract] [Full Text] [Related]

  • 26. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
    Summers AM, Coupes BM, Brennan MF, Ralph SA, Short CD, Brenchley PE.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
    [Abstract] [Full Text] [Related]

  • 27. Modifier genes and sickle cell anemia.
    Steinberg MH, Adewoye AH.
    Curr Opin Hematol; 2006 May; 13(3):131-6. PubMed ID: 16567954
    [Abstract] [Full Text] [Related]

  • 28. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes.
    Wang X, Tomso DJ, Liu X, Bell DA.
    Toxicol Appl Pharmacol; 2005 Sep 01; 207(2 Suppl):84-90. PubMed ID: 16002116
    [Abstract] [Full Text] [Related]

  • 29. Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients.
    Al-Muhanna F, Al-Mueilo S, Al-Ali A, Larbi E, Rubaish A, Abdulmohsen MF, Al-Zahrani A, Al-Ateeq S.
    Saudi J Kidney Dis Transpl; 2008 Nov 01; 19(6):937-41. PubMed ID: 18974580
    [Abstract] [Full Text] [Related]

  • 30. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV, Nunes AC, Rudnicki M, Magistroni R, Albertazzi A, Pereira AC, Krieger JE.
    Nephrol Dial Transplant; 2006 Nov 01; 21(11):3155-63. PubMed ID: 16935894
    [Abstract] [Full Text] [Related]

  • 31. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
    Shu KH, Cheng CH, Wu MJ, Chen CH, Lee WC.
    Ren Fail; 2005 Nov 01; 27(1):53-7. PubMed ID: 15717635
    [Abstract] [Full Text] [Related]

  • 32. Human olfaction: from genomic variation to phenotypic diversity.
    Hasin-Brumshtein Y, Lancet D, Olender T.
    Trends Genet; 2009 Apr 01; 25(4):178-84. PubMed ID: 19303166
    [Abstract] [Full Text] [Related]

  • 33. Study of the association of -667 aquaporin-2 (AQP-2) A/G promoter polymorphism with the incidence and clinical course of chronic kidney disease in Korea.
    Kang SW, Kim YW, Kim YH, Sohn HS, Joo H, Kim E.
    Ren Fail; 2007 Apr 01; 29(6):693-8. PubMed ID: 17763164
    [Abstract] [Full Text] [Related]

  • 34. Life, diversity and the pursuit of haplotypes.
    McCarthy J.
    Nat Biotechnol; 2005 Nov 01; 23(11):1376-7. PubMed ID: 16273067
    [No Abstract] [Full Text] [Related]

  • 35. Genetic susceptibility and single-nucleotide polymorphisms.
    Hanchard NA.
    Semin Fetal Neonatal Med; 2005 Jun 01; 10(3):283-9. PubMed ID: 15927882
    [Abstract] [Full Text] [Related]

  • 36. A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients.
    Kalousová M, Germanová A, Jáchymová M, Mestek O, Tesar V, Zima T.
    Ann N Y Acad Sci; 2008 Apr 01; 1126():268-71. PubMed ID: 18079478
    [Abstract] [Full Text] [Related]

  • 37. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
    Manchanda PK, Kumar A, Kaul A, Mittal RD.
    Clin Chim Acta; 2006 Aug 01; 370(1-2):152-7. PubMed ID: 16545788
    [Abstract] [Full Text] [Related]

  • 38. Computational intelligence in bioinformatics: SNP/haplotype data in genetic association study for common diseases.
    Kelemen A, Vasilakos AV, Liang Y.
    IEEE Trans Inf Technol Biomed; 2009 Sep 01; 13(5):841-7. PubMed ID: 19556205
    [Abstract] [Full Text] [Related]

  • 39. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.
    Buraczynska M, Ksiazek P, Kubit P, Zaluska W.
    Cytokine; 2006 Nov 01; 36(3-4):167-72. PubMed ID: 17224277
    [Abstract] [Full Text] [Related]

  • 40. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease.
    Bellini MH, Figueira MN, Piccoli MF, Marumo JT, Cendoroglo MS, Neto MC, Dalboni MA, Batista MC, Goes MA, Schor N.
    Nephrology (Carlton); 2007 Jun 01; 12(3):289-93. PubMed ID: 17498125
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.